NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









adMare BioInnovations

adMare BioInnovations

Vancouveradmarebio.com

Overview

adMare BioInnovations is a pan-Canadian not-for-profit life sciences venture builder and accelerator that invests pre-seed capital and provides R&D infrastructure and expertise to translate academic research into commercially viable therapeutics.

Year Founded

2019

Portfolio Companies

18

Investments

adMare BioInnovations investments
CompanyDateStageLead
26 Therapeutics Inc.Mar 2026Pre SeedLead
Domain TherapeuticsFeb 2026Series BCo-investor
Kainova TherapeuticsFeb 2026Series BCo-investor
Thryv TherapeuticsSep 2025Series BCo-investor
EpitopeaOct 2024VC RoundLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersVancouver
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.